The BCR gene plays a crucial role in the pathogenesis of leukemias bearing the Philadelphia (Ph) translocation [t(9;22)(q34;qll)] (1). Juxtaposition of the BCR and ABL genes in these leukemias results in the formation of their molecular hallmark-a chimeric BCR-ABL gene (2) (3) (4) . The BCR-ABL fusion protein is capable of inducing chronic myelogenous leukemia (CML)-or acute lymphoblastic leukemia (ALL)-like diseases in mice and can transform lymphoid cells and some types of fibroblasts in vitro and, therefore, is believed to be critical to the oncogenic process (5, 6) ; its transforming ability is related to the activation of the tyrosine kinase enzymatic activity and the actin filament-binding function of ABL by BCR sequences (7) (8) (9) .
Although the role of the normal BCR product in hematopoiesis remains unclear, several functional domains have now been defined for this protein (10) , and it has been implicated at many levels in the two major intracellular signaling mechanisms in eukaryotic cells (phosphorylation and GTPbinding). The first exon [which is the region critical to activating the transforming function of BCR-ABL (10) ] encodes a structurally novel serine/threonine-protein kinase domain (11, 12) . Central BCR sequences show homology to the cdc24 gene (a cell division cycle control gene involved in cytoskeletal organization and the regulation of budding in yeast) and its probable human homologue, the protooncogene DBL (13, 14) .
The C terminus of BCR has homology to a prototype GTPaseactivating protein (GAP) for the RAS-related rho GTPases
The publication costs of this article were defrayed in part by page charge payment. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. §1734 solely to indicate this fact. and has GAP activity for the p2lRAC and the CDC42Hs members of the RAS superfamily of GTP-binding proteins (15) (16) (17) . The above activities are consistent with the immunocytochemistry-based localization of the BCR protein to the cytoplasm in uncycled cells (18, 19 Cell Cycle Synchronization. Synchronization at the G1/S boundary was achieved with aphidicolin block (20) . Cells at 5
x 105 per ml were blocked with 5 jig of aphidicolin per ml for the length of their doubling time and released from the block by three washes in fresh medium. This process was repeated, and the cells were allowed to recover for the length of their S phase before harvesting for analysis. To verify that the cycled cells had been enriched for the G2/M population, DNA content was analyzed by staining DNA with acridine orange (Polysciences) (1.0 mg/ml) and analyzing immediately with FACScan (Becton Dickinson) and Lysis II software (Becton Dickinson).
Cell Sorting. Flow cytometric analysis and cell sorting were performed with the FACS Vantage fluorescence-activated cell sorter (Becton Dickinson) with the Lysis II software. By using nuclear staining with Hoechst 33342 (Polysciences) (which stains DNA while preserving cell viability), gates were set to include cells at Go/G1, S, and G2/M. Cells were collected for immunofluorescence and immunoelectron microscopy studies.
Antisera. For detection of the BCR protein, two antisera were used: (i) rabbit polyclonal sera against the ,-galactosidase-BCR fusion protein (21) , which was affinity-purified by using the glutathione S-transferase-BCR fusion protein; and (ii) monoclonal antibody 7C6 raised against the synthetic peptide bcr686 (Ser-Ser-Ile-Asn-Glu-Glu-Ile-Thr-Pro-ArgArg-Gln-Ser), originally described and characterized by Dhut et at (18) (Oncogene Science). Control antibodies included a preimmune rabbit serum, an isotypic serum, and a monoclonal anti-human mitochondrial serum (Chemicon).
Immunofluorescence for Light and Confocal Microscopy. Immunofluorescence analysis by light and confocal microscopy was performed on paraformaldehyde-fixed cells by methods as described (19) . [To better analyze mitotic cells (where indicated), swelling in 0.075 M KCl for 15 min at room temperature was carried out as an initial step.] Primary anti-BCR antibodies were used at a 1 (rabbit antiserum) or 2 (7C6 serum) ,ug/ml concentration, and incubations were 1 hr at room temperature. In all experiments rabbit preimmune serum or isotypic antibody were used as controls as appropriate for the antibody. In addition, where indicated, blocking of 7C6 serum with the cognate BCR peptide (10-fold excess by weight) was performed by preincubation. The appropriate secondary antibody (fluorescein isothiocyanate) for 7C6 serum and rhodamine for the rabbit antiserum; Jackson ImmunoResearch) was added at a 1:100 dilution for 30 min. Conventional epifluorescence microscopy was performed with an Olympus Vanox AH-2 fluorescence microscope. To specifically label the chromosomes, propidium iodide stain was included in the mounting medium (Imagenetics, Framingham, MA). For dual fluorescence, the Nikon Labophot-2 micro- Immunoelectron Microscopy. For electron microscopy examination, cells were fixed in either 2% glutaraldehyde (Sigma) or in 4% paraformaldehyde/0.1% glutaraldehyde in 0.1 M phosphate buffer (pH 7.3) for 1 hr at 4°C. After a rinse in the same buffer, cells were dehydrated through a series of graded solutions of dimethylformamide (Sigma) (50%, 75%, and 90%, vol/vol) in water at 0°C. Cells were then infiltrated through a series of graded solutions of Lowcryl K4M/dimethylformamide (Polysciences), 1:2, 1:1, and 2:1 (vol/vol), at 0°C and then incubated overnight in 100% Lowcryl K4M at -20°C. Polymerization at -20°C was brought about by indirect overnight ultraviolet irradiation. The blocks were irradiated for another 2-to 3-day period at room temperature to improve the sectioning properties. Thin sections (900 A) were cut with a diamond knife on a Reichert Ultracut E microtome and mounted on Formvar nickel grids (Polysciences).
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Medical Sciences: Wetzler et at laser scanning microscopy ( Fig. 3) and immunoelectron microscopy (Fig. 4 A and B by immunoelectron microscopy demonstrated that nuclear and cytoplasmic localization of BCR actually occurred throughout the cell cycle. The nuclear material specifically labeled was the heterochromatin, with little-to-no labeling of euchromatin. Heterochromatin labeling was diffuse and included the perinuclear heterochromatin, the heterochromatin distributed throughout the nucleus, and the shell of heterochromatin that surrounds the nucleolar bodies and its invaginations into the nucleolus. Results were the same when the cells were fixed with 2% glutaraldehyde (Figs. 4 and 5) or with 4% paraformaldehyde and 0.1% glutaraldehyde (data not shown), but preservation of ultrastructures was better with the 2% glutaraldehyde. Control samples exposed to isotypic antibody showed no labeling (Figs. 4C and SB), and those exposed to an antimitochondrial antibody showed labeling only over the mitochondria (data not shown). Finally, examination of cells by confocal microscopy confirmed nuclear as well as cytoplasmic localization of BCR in interphase cells (data not shown), though by this technique the ratio of cytoplasmic to nuclear BCR was considerably higher than that seen by electron microscopy, perhaps because of differential extraction or masking of antigens in the preparative procedures for electron microscopy as compared with confocal or light microscopy (22, 23) .
DISCUSSION
Heterochromatin is the condensed, transcriptionally inactive form of chromatin (24) . The very highly condensed form of chromatin found in mitotic chromosomes is thought to resemble heterochromatin in its high degree of packing; in addition, mitotic chromosomes are also transcriptionally inactive. Condensation of chromatin is associated with and perhaps responsible for its inactivity. Furthermore, condensation of chromatin is required for progression through the cell cycle and is the prelude to mitosis and cytokinesis. Although several molecules have been shown previously to be associated with chromosomal material, the most prominent are histone proteins. In this regard, nonmitotic heterochromatin has been shown to be biochemically distinct from the transcriptionally active euchromatin. In particular, histone Hi seems to be less tightly bound to at least some active chromatin, and some histone subtypes appear to be more highly phosphorylated in heterochromatin (25) . Serine/threonine phosphorylation of histone Hi is implicated in the control of chromosome condensation (and hence cell cycle progression) (26) . This process is mediated by maturation-promoting factor (MPF), which is composed of CDC2 (a key cell cycle regulatory serine/threonine kinase) and a mitotic cyclin (27, 28) . CDC2 kinase is itself regulated by phosphorylation-dephosphorylation reactions and by its interaction with cyclins (29) . A number of potential substrates for CDC2 in addition to histone Hi have been identified, and they include other proteins that are attached to chromatin [such as the high-mobility-group nonhistone proteins and nucleolin (30) (31) (32) ] and, interestingly, ABL (33) . Although no direct link between BCR and these proteins (other than ABL) has been demonstrated previously, it has been shown that BCR is a serine/threonine kinase that can transphosphorylate histones in vitro (12) .
The presence of BCR in the nucleus and its association with heterochromatin and mitotic chromosomes necessitates a rethinking of its intracellular function and raises the possibility of a role for BCR in chromosomal condensation and perhaps even in cell cycle control. These observations and the postulated serine/threonine kinase activity of BCR lend themselves to further studies examining potential interactions between BCR, other chromatin-associated proteins, and the phosphokinase network that regulates them.
